256 related articles for article (PubMed ID: 31175180)
21. STAT3 mediates TGF-β1-induced TWIST1 expression and prostate cancer invasion.
Cho KH; Jeong KJ; Shin SC; Kang J; Park CG; Lee HY
Cancer Lett; 2013 Aug; 336(1):167-73. PubMed ID: 23623921
[TBL] [Abstract][Full Text] [Related]
22. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
23. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
Lo HW; Hsu SC; Xia W; Cao X; Shih JY; Wei Y; Abbruzzese JL; Hortobagyi GN; Hung MC
Cancer Res; 2007 Oct; 67(19):9066-76. PubMed ID: 17909010
[TBL] [Abstract][Full Text] [Related]
24. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
[TBL] [Abstract][Full Text] [Related]
25. Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Maloney A; Clarke PA; Naaby-Hansen S; Stein R; Koopman JO; Akpan A; Yang A; Zvelebil M; Cramer R; Stimson L; Aherne W; Banerji U; Judson I; Sharp S; Powers M; deBilly E; Salmons J; Walton M; Burlingame A; Waterfield M; Workman P
Cancer Res; 2007 Apr; 67(7):3239-53. PubMed ID: 17409432
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of CMTM3 promotes metastasis of gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Yuan W; Li T; Mo X; Wang X; Liu B; Wang W; Su Y; Xu L; Han W
Oncotarget; 2016 May; 7(20):29507-19. PubMed ID: 27121055
[TBL] [Abstract][Full Text] [Related]
27. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells.
Liu X; Ban LL; Luo G; Li ZY; Li YF; Zhou YC; Wang XC; Jin CG; Ye JG; Ma DD; Xie Q; Huang YG
Anticancer Drugs; 2016 Jun; 27(5):417-26. PubMed ID: 26872308
[TBL] [Abstract][Full Text] [Related]
28. Key role of heat shock protein 90 in leptin-induced STAT3 activation and feeding regulation.
Hosoi T; Kohda T; Matsuzaki S; Ishiguchi M; Kuwamura A; Akita T; Tanaka J; Ozawa K
Br J Pharmacol; 2016 Aug; 173(15):2434-45. PubMed ID: 27205876
[TBL] [Abstract][Full Text] [Related]
29. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
30. PGC1α Cooperates with FOXA1 to Regulate Epithelial Mesenchymal Transition through the TCF4-TWIST1.
Fang XQ; Lee M; Lim WJ; Lee S; Lim CH; Lim JH
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897813
[TBL] [Abstract][Full Text] [Related]
31. Nkx2.8 Inhibits Epithelial-Mesenchymal Transition in Bladder Urothelial Carcinoma via Transcriptional Repression of
Yu C; Liu Z; Chen Q; Li Y; Jiang L; Zhang Z; Zhou F
Cancer Res; 2018 Mar; 78(5):1241-1252. PubMed ID: 29311157
[TBL] [Abstract][Full Text] [Related]
32. The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells.
Schaefer S; Svenstrup TH; Guerra B
PLoS One; 2017; 12(5):e0177706. PubMed ID: 28542269
[TBL] [Abstract][Full Text] [Related]
33. 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.
Sato A; Asano T; Ito K; Asano T
Int J Oncol; 2012 Jul; 41(1):46-52. PubMed ID: 22470109
[TBL] [Abstract][Full Text] [Related]
34. Tristetraprolin suppresses the EMT through the down-regulation of Twist1 and Snail1 in cancer cells.
Yoon NA; Jo HG; Lee UH; Park JH; Yoon JE; Ryu J; Kang SS; Min YJ; Ju SA; Seo EH; Huh IY; Lee BJ; Park JW; Cho WJ
Oncotarget; 2016 Feb; 7(8):8931-43. PubMed ID: 26840564
[TBL] [Abstract][Full Text] [Related]
35. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
36. Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling.
Wetzler M; Earp JC; Brady MT; Keng MK; Jusko WJ
Clin Cancer Res; 2007 Apr; 13(7):2261-70. PubMed ID: 17404111
[TBL] [Abstract][Full Text] [Related]
37. 17-DMAG induces heat shock protein 90 functional impairment in human bladder cancer cells: knocking down the hallmark traits of malignancy.
Karkoulis PK; Stravopodis DJ; Voutsinas GE
Tumour Biol; 2016 May; 37(5):6861-73. PubMed ID: 26662567
[TBL] [Abstract][Full Text] [Related]
38. Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.
Reka AK; Kuick R; Kurapati H; Standiford TJ; Omenn GS; Keshamouni VG
J Thorac Oncol; 2011 Nov; 6(11):1784-92. PubMed ID: 21964532
[TBL] [Abstract][Full Text] [Related]
39. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
40. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
